Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCLA/VA researchers discover fat gene

19.01.2005


Finding may offer new target for controlling obesity, diabetes

UCLA/VA scientists have identified a new gene that controls how the body produces and uses fat. Called lipin, the gene may provide a new target for therapies to control obesity, diabetes and other weight-related disorders. The first issue of the new journal Cell Metabolism publishes the findings in its January 2005 edition.

"Lipin regulates how the body stores and burns fat. Our findings suggest that differences in lipin levels may play a role in why some people are more prone to weight gain than others who consume the same calories," said principal investigator Karen Reue, Ph.D., a professor of medicine and human genetics at the David Geffen School of Medicine at UCLA and a researcher at the Veterans Affairs Greater Los Angeles Healthcare System.



In 2001, Reue’s laboratory was the first to isolate the lipin gene and link it to lipodystrophy, a wasting disorder in which the body is unable to produce fat. She also found that too little lipin prevented both genetic and diet-related obesity.

For this study, Reue and coauthor Jack Phan, Ph.D., tested whether too much lipin would produce the opposite effect. Her team developed animal models using two sets of specially bred mice. Each group had a genetic mutation that boosted the level of lipin – one group in their fat tissue and the other group in their muscles.

When fed a high-fat diet for six weeks, the mice with elevated lipin in their fat or muscles showed accelerated weight gain – double the amount of weight gained by the normal mice. "The mice with too much lipin in their fat tissue or muscles quickly grew obese – gaining more than twice the weight gained by the normal mice on the same diet," said Reue. Although both sets of mice gained excessive weight, the researchers were surprised to see that the lipin affected fat tissue and muscles differently.

Lipin functions in diverse ways to affect body weight. While lipin in fat tissue influences the capacity of cells to store fat – lipin in muscle affects the rate at which the body expends energy and burns fat. "When we increased lipin in the muscle, the cells burned carbohydrates before fat. When lipin is absent, however, the cells burn fat before carbohydrates," explained Reue. "We saw a different effect when lipin acted on fat tissue," she noted. "High levels of lipin promoted fat storage. Lipin deficiency prevented the cells from forming and storing fat."

In other words, the mice with excess lipin in their fat gained weight because their cells stored more fat. The mice with more lipin in their muscle grew obese because the gene repressed their metabolism, causing them to burn fewer calories than normal mice.

In contrast, Reue’s study showed that lipin-deficient mice expended more energy to perform their daily activities. Because lipin moderates calorie use in muscle, its absence caused the mice to burn more calories to fulfill the same tasks as normal mice. "Our study suggests that variations in lipin levels could determine a person’s tendency to gain weight by influencing how their body stores and burns fat," explained Reue. "Prior to our research, scientists typically viewed obesity and emaciation as opposite ends of the spectrum caused by changes in different genes," Reue said. "Yet lipin is a single gene that can regulate body-fat content from one extreme to the other. As a result, it may present a target for the treatment of human diseases related to both excess and insufficient fat."

In an unexpected finding, the study also discovered that lipin levels helped the fat cells metabolize glucose more efficiently, leading to lower blood-sugar levels. The obese mice with excess lipin in their fat tissue demonstrated even lower blood-sugar levels than normal mice with regular levels of lipin. "Because obesity and lipodystrophy are both associated with insulin resistance and high blood sugar, we hope that our results may point to new therapies for diabetes," said Reue.

Elaine Schmidt | EurekAlert!
Further information:
http://www.mednet.ucla.edu

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>